06:21 AM EST, 11/09/2026 (MT Newswires) -- Medclair (MCLR.ST) signed a letter of intent with an unnamed international industrial company to develop and commercialize products based on its new technology platform, according to a Monday release. The planned collaboration covers product development, manufacturing, and commercialization of its medical, dental, and industrial business areas, initially targeting the North American market. The Swedish cleantech company said the parties are working on the technical and commercial requirements toward a definitive cooperation agreement.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.